Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research.

NCT07713667 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT07713667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07713667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research.
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
October 1, 2026
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy